NIH-funded research R01 grant

How immune cells affect high blood pressure

Official title: Immune Modulation in Hypertension

Funded at Indiana University Indianapolis · NIH-11045697 · Data updated 2026-11-12

This study is looking at how immune cells can contribute to damage from high blood pressure and is exploring ways to adjust these immune responses to help protect organs like the kidneys, with the hope of finding new treatments for managing hypertension that won't harm your immune system.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startOctober 20, 2023
Project endFebruary 28, 2026
Funding year2025
Award (this year)$509,727
NIH project number5R01HL161212-04
Project IDNIH-11045697 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are experiencing hypertension.

Less likely to help

Patients with hypertension who have contraindications to immune modulation therapies may not benefit from this research.

What this research studies

This research investigates the role of immune cells in causing damage related to high blood pressure, focusing on how certain immune pathways can lead to inflammation and injury in organs like the kidneys. The team aims to understand how manipulating these immune responses, particularly through a protein called ROCK2, can help restore balance in immune cell types that are currently skewed towards promoting inflammation. By exploring this approach, the researchers hope to develop new therapies that can effectively manage hypertension without compromising the immune system.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for high blood pressure that reduce inflammation and organ damage.

How similar studies have gone: While the approach of targeting immune pathways in hypertension is relatively novel, preliminary studies in animal models have shown promising results.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Madhur, Meenakshi Swaminathan — Indiana University Indianapolis
  • Study coordinator: Madhur, Meenakshi Swaminathan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.